Site-specific immune response to implanted gliomas

Journal of Neurosurgery

Volumn 95, Issue 6, 2001, Pages 1012-1019

  Proescholdt, M A ^a   Merrill, M J ^a   Ikejiri, B ^a   Walbridge, S ^a   Akbasak, A ^a   Jacobson, S ^a   Oldfield, E H ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Apoptosis; Blood brain barrier; Brain tumor; Inflammation; Rat

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; BRAIN TUMOR; CANCER IMMUNOTHERAPY; CLONAL ANERGY; CONTROLLED STUDY; EXPERIMENTAL NEOPLASM; GLIOMA; INFLAMMATORY CELL; LYMPHOCYTIC INFILTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR GROWTH;

EID: 0035205125     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2001.95.6.1012     Document Type: Article

References (44)

1. Expression and modulation of major histocompatibility antigens on murine primary brain tumor in vitro
2. Brain tumors
3. Intratumoral LAK cell and interleukin-2 therapy of human gliomas
4. Evidence for tumor-specific immune response in patients with primary brain tumors
5. Depressed cellmediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor
6. Costimulatory regulation of T cell function
7. The descriptive epidemiology of brain tumors
8. The vasculature of experimental brain tumours. Part 1. A sequential light and electron microscope study of angiogenesis
9. The vasculature of experimental brain tumours. Part 2. A quantitative assessment of morphological abnormalities
10. Immune defects observed in patients with primary malignant brain tumors
11. Novel biologic therapies for malignant gliomas. Anti-Antiangiogenesis, immunotherapy, and gene therapy
12. Human T-cell clonal anergy is induced by antigen presentation in the absence of B 7 costimulation
13. The transplantation of tumors to the brains of heterologous species
14. The role of B7 costimulation in T-cell immunity
15. CNS antigen presentation
16. Induction of effective antitumor immunity in a mouse brain tumor model using B7-B1(CD80) and intercellular adhesive molecule 1 (ICAM-1; CD54) transfection and recombinant interleukin 12
17. B7-1 (CD80)-transfected human glioma cells and interleukin-12 directly stimulate allogeneic CD8+ T cells
18. Tumor antigens in astrocytic gliomas
19. Interpreting MHC class I expression and class I/class II reciprocity in the CNS: Reconciling divergent findings
20. Monoclonal antibody analysis of MHC expression in human brain biopsies: Tissue ranging from "histologically normal" to that showing different levels of glial tumor involvement
21. Capillary ultrastructure and the blood-brain barrier in human malignant brain tumors
22. Adoptive immunotherapy of intracerebral metastases in mice
23. Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutanous tissue, and to the anterior chamber of the eye
24. Immunobiology of the blood-brain barrier
25. Immune surveillance and tumors of the nervous system
26. Immunophenotypic analysis of infiltrating leukocytes and microglia in an experimental rat glioma
27. Response of microglial cells to experimental rat glioma
28. Conditions determining the transplantability of tissues to the brain
29. Glioma immunology and immunotherapy
30. Enriched immune-environment of blood-brain barrier deficient areas of normal adult rats
31. The blood-brain barrier protects foreign antigens in the brain from immune attack
32. Vascular endothelial growth factor (VEGF) modulates vascular permeability and intimation in rat brain
33. The cell biology of the blood-brain barrier
34. Immunohistochemical analysis of tumor-infiltrating lymphocytes and major histocompatibility antigens in human gliomas and metastatic brain tumors
35. Treatment of murine primary brain tumors with systemic interleukin-2 and tumor-infiltrating lymphocytes
36. Is the brain "an immunologically privileged site"? 1. Studies based on intracerebral tumor homotransplantation and isotransplantation to sensitized hosts
37. On the transplantation of the rat sarcoma in adult heterogeneous animals
38. Perivascular lymphocytic cuffing in astrocytomas
39. Differential expression of MHC class II molecules by microglia and neoplastic astroglia: Relevance for the escape of astrocytoma cells from immune surveillance
40. The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-beta, T-cell apoptosis, and the immune privilege of the brain
41. Lymphocyte targeting of the central nervous system: A review of afferent and efferent CNS-immune pathways
42. High-grade astrocytomas
43. Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas
44. Immunotherapy of malignant brain tumors in children and adults: From theoretical principles to clinical application